DRKS00033903招募中不适用
Role of the sphingosine-1-phosphate receptor 1 as a mediator of stroke-induced lymphopenia - S1PR-MSID (S1PR-modulator of stroke-induced immunodepression)
Klinik für Neurologie, Universitätsklinikum Frankfurt, Goethe Universität0 个研究点目标入组 60 人开始时间: 2024年3月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 90 Years（—）
- 性别
- All
入选标准
- •Clinical and radiological diagnosis of acute ischemic stroke
- •- Time between symptom onset or last asymptomatic contact and hospital admission <24h
排除标准
- •- Malignant disease
- •- Pre-existing disease of the central nervous system
- •- NIHSS>20 points
- •- Age >90 years
研究者
相似试验
招募中
不适用
Clinical Significance of Sphingosine-1-Phosphate in the Evaluation of Endothelial Function and Cardiovascular Risk in HypertensioEssential hypertensionJPRN-UMIN000004497agoya City University Graduate School of Medical Sciences30
招募中
不适用
Clinical Significance of Sphingosine-1-Phosphate in the Evaluation of Endothelial Function and Cardiovascular Risk in DyslipidemiadyslipidemiaJPRN-UMIN000004116agoya City University Graduate School of Medical Sciences60
招募中
不适用
Sphingosine 1-phosphate (S1P) mediated adaptations to hypoxemic conditions in red blood cells (RBC) in acute and chronic respiratory diseasesAcute and chronic pulmonary diseaseDRKS00027837niversitätsmedizin Göttingen240
进行中（未招募）
1 期
Does targeting of S1P receptors reduce microglial activation in multiple sclerosis?Multiple sclerosisEUCTR2013-004626-28-FITurku University Hospital60
已完成
不适用
Ceramide/Sphingosine-1-phosphate in patients with Hypertension Compared with normotensive controls: a case-control StudyBloeddrukregulatieHypertension en verhoogde bloeddruk10013317NL-OMON40437Erasmus MC, Universitair Medisch Centrum Rotterdam40